stars 1 stars 2 stars 3

GitLife Biotech | Synthetic Biology & Bio-Digital Innovation GitLife Biotech was a pioneering deep-tech company developing innovative solutions for the identification, traceability and protection of engineered biological assets. Its flagship technology, CellRepo (GitLife), was a bio-digital platform designed to bring version control to biology — combining biological barcoding with digital traceability to establish provenance, protect intellectual property, enable secure collaboration and support biosecurity. Often described as "GitHub for Biology", the company's vision was to make biological innovation more transparent, traceable and secure, helping researchers and biotechnology companies manage and protect their valuable biological assets from early research through to commercialisation. GitLife Biotech has now ceased operations. This page remains as a record of the company's technology, vision and the contributions of those involved in its journey.

GitLife Biotech Questions

Harry Jackson is the Director of Synthetic Biology of GitLife Biotech.

3 people are employed at GitLife Biotech.

GitLife Biotech is based in Newcastle, England.

Top GitLife Biotech Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users